ESR2 and breast cancer: For this purpose, we developed and characterized 3D BC cell-derived spheroid models from the aggressive ERβ-very low/negative TNBC cell lines (shERβ MDA-MB-231 and Hs578T), evaluating the functional and molecular consequences on ECM remodeling and mesenchymal signaling.